Volume 51, Issue 8

Search all European Journal of Nuclear Medicine and Molecular Imaging articles

July 2024

37 articles in this issue

Letter to the editor concerning “Cardiac [99mTc]Tc-hydroxydiphosphonate uptake on bone scintigraphy in patients with hereditary transthyretin amyloidosis: an early follow-up marker?”
An-Li Yu
Cheng-Hsuan Tsai
Yen-Hung Lin
Letter to the Editor 24 April 2024 Pages: 2161 - 2162
Part of 1 collection:

Molecular imaging in cardiac amyloidosis
Collection on molecular imaging in cardiac amyloidosis
Federico Caobelli
Christoph Rischpler
Editorial 07 May 2024 Pages: 2163 - 2164
Part of 1 collection:

Molecular imaging in cardiac amyloidosis
How nuclear imaging changed parathyroid surgical strategies through time
H. M. Schouw
M. E. Noltes
S. Kruijff
Editorial 23 April 2024 Pages: 2165 - 2171
The status of nuclear medicine in China: the first official national survey
Haiqiong Zhang
** Zheng
Li Huo
Original Article 02 April 2024 Pages: 2172 - 2178
Preclinical evaluation of EpCAM-binding designed ankyrin repeat proteins (DARPins) as targeting moieties for bimodal near-infrared fluorescence and photoacoustic imaging of cancer
Ruben D. Houvast
Nada Badr
Cornelis F. M. Sier
Original Article Open access 29 August 2023 Pages: 2179 - 2192
Part of 1 collection:

Photoacoustic imaging
Preclinical validation of a novel brain-penetrant PET ligand for visualization of histone deacetylase 6: a potential imaging target for neurodegenerative diseases
Tetsuro Tago
Muneyuki Sakata
Jun Toyohara
Original Article 05 March 2024 Pages: 2193 - 2203
Early detection of anthracycline-induced cardiotoxicity using [⁶⁸ Ga]Ga-FAPI-04 imaging
Zhuxin Wei
Hongchuang Xu
Shihua Zhao
Original Article 16 March 2024 Pages: 2204 - 2215
Macrophage mannose receptor CD206 targeting of fluoride-18 labeled mannosylated dextran: A validation study in mice
Putri Andriana
Ruth Fair-Mäkelä
Anne Roivainen
Original Article Open access 27 March 2024 Pages: 2216 - 2228
Diagnostic imaging of the diabetic foot: an EANM evidence-based guidance
Chiara Lauri
Edel Noriega-Álvarez
Alberto Signore
Original Article Open access 27 March 2024 Pages: 2229 - 2246
A systematic review for the evidence of recommendations and guidelines in hybrid nuclear cardiovascular imaging
Florent L. Besson
Giorgio Treglia
Riemer H. J. A. Slart
Review Article Open access 15 January 2024 Pages: 2247 - 2259
Thoracic aortic microcalcification activity in combined positron emission tomography and magnetic resonance imaging
Jennifer Nash
Samuel Debono
Alexander J Fletcher
Original Article Open access 08 March 2024 Pages: 2260 - 2270
Exploring the nigrostriatal and digestive interplays in Parkinson’s disease using dynamic total-body [¹¹C]CFT PET/CT
Mei **n
Yihan Wang
Jianjun Liu
Original Article 23 February 2024 Pages: 2271 - 2282
Part of 1 collection:

Molecular Imaging in Neurodegeneration
Non-invasive assessment of stimulation-specific changes in cerebral glucose metabolism with functional PET
Godber Mathis Godbersen
Pia Falb
Andreas Hahn
Original Article Open access 16 March 2024 Pages: 2283 - 2292
Artificial intelligence–based, volumetric assessment of the bone marrow metabolic activity in [¹⁸F]FDG PET/CT predicts survival in multiple myeloma
Christos Sachpekidis
Olof Enqvist
Antonia Dimitrakopoulou-Strauss
Original Article Open access 08 March 2024 Pages: 2293 - 2307
[¹⁸F]FDG PET/CT for prognosis and toxicity prediction of diffuse large B-cell lymphoma patients with chimeric antigen receptor T-cell therapy
**bo Gui
Mengting Li
**aoli Lan
Original Article 12 March 2024 Pages: 2308 - 2319
Guiding principles on the education and practice of theranostics
Thomas N. B. Pascual
Diana Paez
Andrew M. Scott
Original Article Open access 08 March 2024 Pages: 2320 - 2331
Targeted interleukin-2 enhances the in vivo anti-cancer activity of Pluvicto™
Tony Georgiev
Lucrezia Principi
Samuele Cazzamalli
Short Communication 02 April 2024 Pages: 2332 - 2337
Homodimeric peptide radiotracer [⁶⁸Ga]Ga-NOTA-(TMVP1)₂ for VEGFR-3 imaging of cervical cancer patients
** Chen
Zhenzhong Zhang
Ling **
Original Article 27 February 2024 Pages: 2338 - 2352
Part of 1 collection:

Preclinical Molecular Imaging and Cancer Theranostics
Intelligent ultrafast total-body PET for sedation-free pediatric [¹⁸F]FDG imaging
**ang Zhou
Yu Fu
Kuangyu Shi
Original Article 22 February 2024 Pages: 2353 - 2366
EANM position on positron emission tomography in suspected functional pituitary neuroendocrine tumours
Donatienne Van Weehaeghe
Bruno Lapauw
Elsmarieke Van De Giessen
Editorial 30 April 2024 Pages: 2367 - 2370
Enhancing predictability of IDH mutation status in glioma patients at initial diagnosis: a comparative analysis of radiomics from MRI, [¹⁸F]FET PET, and TSPO PET
Lena Kaiser
S. Quach
N. L. Albert
Original Article Open access 24 February 2024 Pages: 2371 - 2381
Fiat lux: the dawn of fluorescence in molecular imaging of differentiated thyroid cancer
Frederik A. Verburg
Stijn Keereweer
Editorial 02 December 2023 Pages: 2382 - 2383
MET-receptor targeted fluorescent imaging and spectroscopy to detect multifocal papillary thyroid cancer
Madelon J. H. Metman
Pascal K. C. Jonker
Schelto Kruijff
Original Article Open access 29 November 2023 Pages: 2384 - 2394
Disrupted gut microecology after high-dose ¹³¹I therapy and radioprotective effects of arachidonic acid supplementation
Ganghua Lu
Dingwei Gao
Zhongwei Lv
Original Article Open access 02 April 2024 Pages: 2395 - 2408
Preoperative evaluation of mediastinal lymph nodes in non-small cell lung cancer using [⁶⁸Ga]FAPI-46 PET/CT: a prospective pilot study
Yeon-koo Kang
Kwon Joong Na
Young Tae Kim
Original Article Open access 07 March 2024 Pages: 2409 - 2419
Altered biodistribution of [⁶⁸Ga]Ga-DOTA-TOC during somatostatin analogue treatment
T. van de Weijer
F. Bemer
F. M. Mottaghy
Original Article Open access 26 February 2024 Pages: 2420 - 2427
Dosimetry and pharmacokinetics of [¹⁷⁷Lu]Lu-satoreotide tetraxetan in patients with progressive neuroendocrine tumours
Seval Beykan Schürrle
Uta Eberlein
Michael Lassmann
Original Article Open access 26 March 2024 Pages: 2428 - 2441
Biological characterization of renal masses using immuno-PET
Fabrizia Gelardi
Alessandro Larcher
Arturo Chiti
Editorial 11 May 2024 Pages: 2442 - 2443
ImmunoPET/CT imaging of clear cell renal cell carcinoma with [¹⁸F]RCCB6: a first-in-human study
Qianyun Wu
Yanfei Wu
Weijun Wei
Original Article 14 March 2024 Pages: 2444 - 2457
Initial [18F]DCFPyL PET/CT in treatment-naïve prostate cancer: correlation with post-ADT PSA outcomes and recurrence
Yuekai Li
Shiwei Wang
**ang Li
Short Communication 02 April 2024 Pages: 2458 - 2466
Whole-body tumour burden on [18F]DCFPyL PET/CT in biochemical recurrence of prostate cancer: association with tumour biology and PSA kinetics
Laura García-Zoghby
Mariano Amo-Salas
Ana María García Vicente
Original Article 23 March 2024 Pages: 2467 - 2483
The superior detection rate of total-body [⁶⁸Ga]Ga-PSMA-11 PET/CT compared to short axial field-of-view [⁶⁸Ga]Ga-PSMA-11 PET/CT for early recurrent prostate cancer patients with PSA < 0.2 ng/mL after radical prostatectomy
Yining Wang
Liang Dong
Ruohua Chen
Original Article 22 March 2024 Pages: 2484 - 2494
Part of 1 collection:

Total Body PET
[¹⁷⁷Lu]Lu-PSMA-617 as first-line systemic therapy in patients with metastatic castration-resistant prostate cancer: a real-world study
Swayamjeet Satapathy
Madhav Prasad Yadav
Chandrasekhar Bal
Original Article 12 March 2024 Pages: 2495 - 2503
Image-based dosimetry for [²²⁵Ac]Ac-PSMA-I&T therapy and the effect of daughter-specific pharmacokinetics
Grigory Liubchenko
Guido Böning
Astrid Delker
Original Article Open access 21 March 2024 Pages: 2504 - 2514
Tau aggregation following subcortical hemorrhage
Elena Jaeger
Gérard N. Bischof
Alexander Drzezga
Image of the Month Open access 04 March 2024 Pages: 2515 - 2516
First-in-human administration of terbium-161-labelled somatostatin receptor subtype 2 antagonist ([¹⁶¹Tb]Tb-DOTA-LM3) in a patient with a metastatic neuroendocrine tumour of the ileum
Julia Fricke
Frida Westerbergh
Damian Wild
Image of the Month Open access 07 March 2024 Pages: 2517 - 2519
[⁶⁸Ga]Ga-FAPI versus [¹⁸F]FDG PET/CT in the evaluation of Langerhans cell histiocytosis
Linlin Guo
Guohua Shen
Image of the Month 09 March 2024 Pages: 2520 - 2521

Volume 51, Issue 8

Letter to the editor concerning “Cardiac [99mTc]Tc-hydroxydiphosphonate uptake on bone scintigraphy in patients with hereditary transthyretin amyloidosis: an early follow-up marker?”

Collection on molecular imaging in cardiac amyloidosis

How nuclear imaging changed parathyroid surgical strategies through time

The status of nuclear medicine in China: the first official national survey

Preclinical evaluation of EpCAM-binding designed ankyrin repeat proteins (DARPins) as targeting moieties for bimodal near-infrared fluorescence and photoacoustic imaging of cancer

Preclinical validation of a novel brain-penetrant PET ligand for visualization of histone deacetylase 6: a potential imaging target for neurodegenerative diseases

Early detection of anthracycline-induced cardiotoxicity using [⁶⁸ Ga]Ga-FAPI-04 imaging

Macrophage mannose receptor CD206 targeting of fluoride-18 labeled mannosylated dextran: A validation study in mice

Diagnostic imaging of the diabetic foot: an EANM evidence-based guidance

A systematic review for the evidence of recommendations and guidelines in hybrid nuclear cardiovascular imaging

Thoracic aortic microcalcification activity in combined positron emission tomography and magnetic resonance imaging

Exploring the nigrostriatal and digestive interplays in Parkinson’s disease using dynamic total-body [¹¹C]CFT PET/CT

Non-invasive assessment of stimulation-specific changes in cerebral glucose metabolism with functional PET

Artificial intelligence–based, volumetric assessment of the bone marrow metabolic activity in [¹⁸F]FDG PET/CT predicts survival in multiple myeloma

[¹⁸F]FDG PET/CT for prognosis and toxicity prediction of diffuse large B-cell lymphoma patients with chimeric antigen receptor T-cell therapy

Guiding principles on the education and practice of theranostics

Targeted interleukin-2 enhances the in vivo anti-cancer activity of Pluvicto™

Homodimeric peptide radiotracer [⁶⁸Ga]Ga-NOTA-(TMVP1)₂ for VEGFR-3 imaging of cervical cancer patients

Intelligent ultrafast total-body PET for sedation-free pediatric [¹⁸F]FDG imaging

EANM position on positron emission tomography in suspected functional pituitary neuroendocrine tumours

Enhancing predictability of IDH mutation status in glioma patients at initial diagnosis: a comparative analysis of radiomics from MRI, [¹⁸F]FET PET, and TSPO PET

Fiat lux: the dawn of fluorescence in molecular imaging of differentiated thyroid cancer

MET-receptor targeted fluorescent imaging and spectroscopy to detect multifocal papillary thyroid cancer

Disrupted gut microecology after high-dose ¹³¹I therapy and radioprotective effects of arachidonic acid supplementation

Preoperative evaluation of mediastinal lymph nodes in non-small cell lung cancer using [⁶⁸Ga]FAPI-46 PET/CT: a prospective pilot study

Altered biodistribution of [⁶⁸Ga]Ga-DOTA-TOC during somatostatin analogue treatment

Dosimetry and pharmacokinetics of [¹⁷⁷Lu]Lu-satoreotide tetraxetan in patients with progressive neuroendocrine tumours

Biological characterization of renal masses using immuno-PET

ImmunoPET/CT imaging of clear cell renal cell carcinoma with [¹⁸F]RCCB6: a first-in-human study

Initial [18F]DCFPyL PET/CT in treatment-naïve prostate cancer: correlation with post-ADT PSA outcomes and recurrence

Whole-body tumour burden on [18F]DCFPyL PET/CT in biochemical recurrence of prostate cancer: association with tumour biology and PSA kinetics

The superior detection rate of total-body [⁶⁸Ga]Ga-PSMA-11 PET/CT compared to short axial field-of-view [⁶⁸Ga]Ga-PSMA-11 PET/CT for early recurrent prostate cancer patients with PSA < 0.2 ng/mL after radical prostatectomy

[¹⁷⁷Lu]Lu-PSMA-617 as first-line systemic therapy in patients with metastatic castration-resistant prostate cancer: a real-world study

Image-based dosimetry for [²²⁵Ac]Ac-PSMA-I&T therapy and the effect of daughter-specific pharmacokinetics

Tau aggregation following subcortical hemorrhage

First-in-human administration of terbium-161-labelled somatostatin receptor subtype 2 antagonist ([¹⁶¹Tb]Tb-DOTA-LM3) in a patient with a metastatic neuroendocrine tumour of the ileum

[⁶⁸Ga]Ga-FAPI versus [¹⁸F]FDG PET/CT in the evaluation of Langerhans cell histiocytosis

Navigation